Christopher Hourigan is an Oncology physician. OpenAlex indexes 259 publications with 11,361 citations (h-index 44); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingClinical trials
- Molecular Evaluation of AML Patients After Stem Cell Transplant to Understand Relapse Events
Sponsor: Center for International Blood and Marrow Transplant Research
- Pembrolizumab and Decitabine for Refractory or Relapsed Acute Myeloid Leukemia
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
- Biomarkers for Personalized Early Assessment of Response During Salvage Chemotherapy in People With Relapsed or Refractory Acute Myeloid Leukemia (PEARL15)
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AstellasProgram year20251 payment
- Syndax PharmaceuticalsProgram year20252 payments
- JanssenProgram year20251 payment
Services and research payments matched to this physician's NPI in CMS Open Payments. Meals, travel and gifts are counted in the company total and not listed here.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Beth Karlan, MD
University of California, Los Angeles
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”